Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Validity of six consumer-level activity monitors for measuring steps in patients with chronic heart failure

T. Vetrovsky, M. Siranec, J. Marencakova, JJ. Tufano, V. Capek, V. Bunc, J. Belohlavek,

. 2019 ; 14 (9) : e0222569. [pub] 20190913

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc20005910

INTRODUCTION: Although numerous activity trackers have been validated in healthy populations, validation is lacking in chronic heart failure patients who normally walk at a slower pace, making it difficult for researchers and clinicians to implement activity monitors during physical activity interventions. METHODS: Six consumer-level activity monitors were validated in a 3-day field study in patients with chronic heart failure and healthy individuals under free living conditions. Furthermore, the same devices were evaluated in a lab-based study during treadmill walking at speeds of 2.4, 3.0, 3.6, and 4.2 km·h-1. Concordance correlation coefficients (CCC) were used to evaluate the agreement between the activity monitors and the criterion, and mean absolute percentage errors (MAPE) were calculated to assess differences between each device and the criterion (MAPE <10% was considered as a threshold for validity). RESULTS: In the field study of healthy individuals, all but one of the activity monitors showed a substantial correlation (CCC ≥0.95) with the criterion device and MAPE <10%. In patients with heart failure, the correlation of only two activity monitors (Garmin vívofit 3 and Withings Go) was classified as at least moderate (CCC ≥0.90) and none of the devices had MAPE <10%. In the lab-based study at speeds 4.2 and 3.6 km·h-1, all activity monitors showed substantial to almost perfect correlations (CCC ≥0.95) with the criterion and MAPE in the range 1%-3%. However, at slower speeds of 3.0 and 2.4 km·h-1, the accuracy of all devices substantially deteriorated: their correlation with the criterion decreased below 90% and their MAPE increased to 4-8% and 10-45%, respectively. CONCLUSIONS: Even though none of the tested activity monitors fall within arbitrary thresholds for validity, most of them perform reasonably well enough to be useful tools that clinicians can use to simply motivate chronic heart failure patients to walk more.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20005910
003      
CZ-PrNML
005      
20200518132203.0
007      
ta
008      
200511s2019 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1371/journal.pone.0222569 $2 doi
035    __
$a (PubMed)31518367
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Vetrovsky, Tomas $u Faculty of Physical Education and Sport, Charles University, Prague, Czech Republic.
245    10
$a Validity of six consumer-level activity monitors for measuring steps in patients with chronic heart failure / $c T. Vetrovsky, M. Siranec, J. Marencakova, JJ. Tufano, V. Capek, V. Bunc, J. Belohlavek,
520    9_
$a INTRODUCTION: Although numerous activity trackers have been validated in healthy populations, validation is lacking in chronic heart failure patients who normally walk at a slower pace, making it difficult for researchers and clinicians to implement activity monitors during physical activity interventions. METHODS: Six consumer-level activity monitors were validated in a 3-day field study in patients with chronic heart failure and healthy individuals under free living conditions. Furthermore, the same devices were evaluated in a lab-based study during treadmill walking at speeds of 2.4, 3.0, 3.6, and 4.2 km·h-1. Concordance correlation coefficients (CCC) were used to evaluate the agreement between the activity monitors and the criterion, and mean absolute percentage errors (MAPE) were calculated to assess differences between each device and the criterion (MAPE <10% was considered as a threshold for validity). RESULTS: In the field study of healthy individuals, all but one of the activity monitors showed a substantial correlation (CCC ≥0.95) with the criterion device and MAPE <10%. In patients with heart failure, the correlation of only two activity monitors (Garmin vívofit 3 and Withings Go) was classified as at least moderate (CCC ≥0.90) and none of the devices had MAPE <10%. In the lab-based study at speeds 4.2 and 3.6 km·h-1, all activity monitors showed substantial to almost perfect correlations (CCC ≥0.95) with the criterion and MAPE in the range 1%-3%. However, at slower speeds of 3.0 and 2.4 km·h-1, the accuracy of all devices substantially deteriorated: their correlation with the criterion decreased below 90% and their MAPE increased to 4-8% and 10-45%, respectively. CONCLUSIONS: Even though none of the tested activity monitors fall within arbitrary thresholds for validity, most of them perform reasonably well enough to be useful tools that clinicians can use to simply motivate chronic heart failure patients to walk more.
650    _2
$a akcelerometrie $x přístrojové vybavení $x metody $7 D061725
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a chronická nemoc $7 D002908
650    _2
$a cvičení $x fyziologie $7 D015444
650    _2
$a zátěžový test $x přístrojové vybavení $x metody $7 D005080
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a fitness náramky $7 D000072936
650    _2
$a srdeční selhání $x patofyziologie $7 D006333
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a ambulantní monitorování $x přístrojové vybavení $x metody $7 D018670
650    _2
$a reprodukovatelnost výsledků $7 D015203
650    _2
$a chůze $x fyziologie $7 D016138
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Siranec, Michal $u 2nd Department of Medicine - Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
700    1_
$a Marencakova, Jitka $u Faculty of Physical Education and Sport, Charles University, Prague, Czech Republic.
700    1_
$a Tufano, James J $u Faculty of Physical Education and Sport, Charles University, Prague, Czech Republic.
700    1_
$a Capek, Vaclav $u Second Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Bunc, Vaclav $u Faculty of Physical Education and Sport, Charles University, Prague, Czech Republic.
700    1_
$a Belohlavek, Jan $u 2nd Department of Medicine - Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
773    0_
$w MED00180950 $t PloS one $x 1932-6203 $g Roč. 14, č. 9 (2019), s. e0222569
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31518367 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20200511 $b ABA008
991    __
$a 20200518132203 $b ABA008
999    __
$a ok $b bmc $g 1524768 $s 1095966
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 14 $c 9 $d e0222569 $e 20190913 $i 1932-6203 $m PLoS One $n PLoS One $x MED00180950
LZP    __
$a Pubmed-20200511

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...